60s singer Bobby Rydell gets double organ transplant, set to be released from Pa. hospital
Bobby Rydell Undergoes Liver and Kidney Transplant
PHILADELPHIA (AP) – Sixties teen idol Bobby Rydell has undergone a liver and kidney transplant in Philadelphia. The 70-year-old singer of hits including "Wild One" and "Volare" had surgery last week. He tells KYW-AM that his doctor …
Former teen idol gets double transplant
SIXTIES teen idol Bobby Rydell has undergone a liver and kidney transplant in Philadelphia.
Abbott Reports Strong Second Quarter Results – Equities.com
Abbott Reports Strong Second Quarter ResultsEquities.comAbbott is partnering on the development of a novel, next-generation antibody, daclizumab, which is currently in Phase 3 clinical trials for MS. Additionally, Abbott recently announced positive res…
Abbott Beats on EPS, Affirms View – Analyst Blog – NASDAQ
RTT NewsAbbott Beats on EPS, Affirms View – Analyst BlogNASDAQAbbott Labs, along with partner Biogen ( BIIB ), is evaluating daclizumab in a phase III study for the treatment of relapsing-remitting multiple sclerosis (RRMS). Abbott Labs is also working…
60s singer Rydell gets double organ transplant
PHILADELPHIA—Sixties teen idol Bobby Rydell is recovering from a liver and kidney transplant at a Philadelphia hospital.
60s singer Rydell gets 2 organ transplants in Pa.
Sixties teen idol Bobby Rydell has undergone a liver and kidney transplant in Philadelphia.
Bridging gaps in organ transplantation
New Delhi, July 18: It has been estimated that two hundred thousand people in India are annually diagnosed with organ failure needing transplantation as part of life saving measure.
Number of people kept alive by organ donation or dialysis almost triples – Adelaide Now
Number of people kept alive by organ donation or dialysis almost triplesAdelaide NowTo register with the Australian Organ Donor Register, log on to www.medicareaustralia.gov.au and follow the link, ask at your local Medicare branch or call 1800 777 203…
Abbott Beats on EPS, Affirms View – Zacks.com
Abbott Beats on EPS, Affirms ViewZacks.comAbbott Labs, along with partner Biogen (BIIB – Analyst Report), is evaluating daclizumab in a phase III study for the treatment of relapsing-remitting multiple sclerosis (RRMS). Abbott Labs is also working on l…